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Population-based studies of headache disorders are important. They inform needs assessment and underpin service
policy for a set of disorders that are a public-health priority. On the one hand, our knowledge of the global burden
of headache is incomplete, with major geographical gaps; on the other, methodological differences and variable
quality are notable among published studies of headache prevalence, burden and cost.
The purpose here was to start the process of developing standardized and better methodology in these studies. An
expert consensus group was assembled to identify the key methodological issues, and areas where studies might
fail. Members had competence and practical experience in headache epidemiology or epidemiology in general,
and were drawn from all WHO world regions. We reviewed the relevant literature, and supplemented the
knowledge gathered from this exercise with experience gained from recent Global Campaign population-based
studies, not all yet published. We extracted methodological themes and identified issues within them that were of
key importance.
We found wide variations in methodology. The themes within which methodological shortcomings had adverse
impact on quality were the following: study design; selection and/or definition of population of interest; sampling
and bias avoidance; sample size estimation; access to selected subjects (managing and reporting non-participation);
case definition (including diagnosis and timeframe); case ascertainment (including diagnostic validation of
questionnaires); burden estimation; reporting (methods and results). These are discussed.
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Epidemiological studies of headache are important. They
enhance our understanding of its origins, patterns, aeti-
ology and risk factors, so improving opportunities for
treatment and prevention of headache. They inform needs
assessment, underpin service policy and push for accept-
ance of headache disorders as a public-health priority.
They gain in importance because headache disorders are
themselves important, a fact greatly emphasized by the* Correspondence: t.steiner@imperial.ac.uk
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in any medium, provided the original work is pGlobal Burden of Disease Study 2010 (GBD2010) led by
the Institute of Health Metrics and Evaluation, which
placed headache disorders among the top ten causes of
disability worldwide [1].
GBD2010 measured “burden” in terms of disability-
adjusted life years (DALYs), a metric derived by sum-
ming years of life lost to premature mortality (YLLs) and
years lost to disability (YLDs). Only the latter are rele-
vant to headache disorders. These are undoubtedly use-
ful concepts for making comparisons between diseases,
informative especially for health policy formulation and
health-care resource allocation, but they are narrow
measures nonetheless. We use “burden of disease” to mean
all the negative consequences of living with a disease,
although in practice not all are measurable.n Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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plete. The numerous published studies of headache preva-
lence, and the not so many of burden, are notably focused
on the western world and on migraine [2]. The Global
Campaign against Headache has been active in redressing
this [3-6], but the evidence adduced for GBD2010 had
major gaps, especially in African, South-East Asia and
Eastern Mediterranean Regions. In addition, methodo-
logical differences and variable quality have both been
major factors influencing findings among the studies
reviewed by Stovner et al. [2]. While more population-
based studies of headache disorders are certainly called
for, the need for standardized – and better – methodology
in such studies has long been evident [2,7].
The purpose of this document, a product of the Global
Campaign against Headache [7-9], is to start the process
of meeting this need. In highlighting the key methodo-
logical issues, it draws attention to areas where studies
may fail, despite commitment to them of much money
and time. It concentrates on issues that relate specifically
or are of particular relevance to headache; discussion of
general epidemiological principles is avoided. Even more,
the focus is on headache disorders of public-health interest:
migraine and tension-type headache (TTH). Medication-
overuse headache (MOH) is also included because, on
present understanding, it arises only as a complication of
a pre-existing headache disorder, usually migraine. Un-
questionably, MOH contributes to public ill-health [8,9].
Procedure
The process was led by Lifting The Burden (LTB), a
non-governmental organization conducting the Global
Campaign against Headache in official relations with
the World Health Organization (WHO) [10-13]. LTB
assembled an expert consensus group (the co-authors),
selecting members to bring experience and competence
in headache epidemiology and/or epidemiology in
general, to include WHO staff members with expertise
in these fields, and, in pursuit of international and
cross-cultural relevance, to have personal knowledge of
all six WHO world regions.
We reviewed the relevant literature. Reviews of the
world literature on headache epidemiology had been
performed already, in earlier initiatives to document the
prevalence and burden of headache [2,14-16] and the
methodological issues arising from their measurement
[7]. These reviews had been updated by LJS and TJS in
the process of submitting evidence for GBD2010 [1]. We
supplemented the knowledge gathered from these with
more recent experience gained from LTB-supported
population-based studies: four completed in Russia [3],
China [4], India [5] and Pakistan [6], and three others
still in progress and not yet published in Saudi Arabia,
Zambia and Ethiopia. We extracted methodologicalthemes and, within these, identified the areas in which
methodological shortcomings with detrimental effect on
quality were evident.
The expert group first acted as a sounding board in
this process, conducted initially by email, and then con-
vened as a consensus group at a meeting in Trondheim
in August 2011. Through critical review, we applied a
process of item reduction and distillation, retaining only
those themes and issues arising from them that we con-
sidered of key importance. Final consensus was achieved
through further email exchanges.
Results
As anticipated, we found wide variations in reported
methodology. The themes within which, in our view,
methodological shortcomings had adverse impact on
quality were the following:
 Study design;
 Selection and/or definition of population of interest;
 Sampling and bias avoidance;
 Sample size estimation;
 Access to selected subjects (managing and reporting
non-participation);
 Case definition (including diagnosis and timeframe);
 Case ascertainment (including diagnostic validation
of questionnaires);
 Burden estimation;
 Reporting (methods and results).
Our findings are summarized under these themes in
Table 1, and are expanded below. Where we give exam-
ples, these are from studies that were generally of good
quality but fell down in specific areas; we did not make
a register of studies that were overall of poor quality.
On study design, most studies were descriptive,
estimating headache prevalence and/or burden, and had
cross-sectional designs adequate for this purpose. An
occasionally recurring methodological error seen in
some of these was the reporting of “risk factors” despite
that cross-sectional studies can provide evidence only of
association, not causation [17,18]. A few studies had
more analytical aims, explicitly attempting to define
causes of or risk factors for headache, and adopted
appropriate case-control or cohort designs.
We found studies that had not correctly defined the
population of interest for their purposes; instead they
surveyed groups of people chosen more for convenience
[19-21]. Often these were studies of patient populations.
We did not make a register of the very poor studies that
attempted to infer population prevalence from patient
samples, although there were examples of this.
Not all studies adopted methods of sampling from the
population of interest with due concern for bias avoidance.
Table 1 Methodological themes from the literature review, and shortcomings detrimental to quality
Theme Methodological issue Potential impact on quality
Study design Inappropriately selected for overall purpose Very high
Unsuited to secondary purpose(s) Low
Population of interest Inappropriately selected for purpose Very high
Inadequately defined High or very high
Sampling method (including means of access) Systematically bias generating Moderate to high
Inadequately reported High
Sample size Inadequate for purpose Low to high
Non-participation Excessively reducing sample size Low to high
Bias generating Moderate to high
Inadequately reported High or very high
Case definition Not according to accepted diagnostic criteria Moderate to high
Inadequately reported High or very high
Applying inappropriate or undefined timeframe High or very high
Case ascertainment Not according to accepted diagnostic criteria Moderate to high
Employing unvalidated diagnostic methods Moderate to high
Inadequately reported High
Burden estimation Not relevant Low to moderate
Not comprehensive Low
Reporting Not adequately descriptive of methods Low to high
Not adequately descriptive of results Moderate to high
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recognized, or sought to quantify or manage, the risk of
bias arising from uneven distribution of telephones
across different age, gender and socioeconomic groups
[22-39]. Among those making contact with households,
either by telephone or visiting, not all explicitly avoided
selection bias arising when the person interviewed was
whoever happened to answer. Some studies did not ad-
equately describe their sampling methods – how house-
holds or individuals were selected such that a selection
probability could be assigned to them.
We found headache surveys with sample sizes clearly
too small for their stated purposes. We did not register
these. In many cases, sample sizes were greatly reduced
by high levels of non-participation [40-45]. We found,
more seriously because no remedy could be offered,
other studies in which levels of participation were not
reported [20,21,33,37,38,46-79].
Access methods in published studies included visits to
households and calls to telephones (land-line or mobile),
usually in either case without prior warning (cold-calling).
The methods were not always adequately described: in
particular, accounts were rarely given of the management
of apparently empty households or of unanswered tele-
phone calls. Also used were access by mail or e-mail [40].
Participation levels were invariably low in such studies,
such that adequate management of selection bias wasvirtually impossible. Some studies summoned prospective
participants to the interviewer [80,81], again not always
with adequate management of selection bias.
The great majority of published studies applied case
definitions in some manner according to the criteria of
ICHD-II [82] or the earlier ICHD-I [83]. Not all did so
in the same way: “migraine” in some included all of its
subtypes (ICHD-II codes 1.1-1.6) but in others only
migraine with or without aura (ICHD-II codes 1.1 and
1.2). The terms “migraine” and “tension-type headache”
included both episodic and chronic forms of each, or
were restricted to the episodic forms, with the chronic
forms subsumed within the category of headache occur-
ring on ≥15 days/month (often referred to as “chronic
daily headache”). Several studies separately reported the
prevalences of migraine and probable migraine [84-88],
establishing case definitions implying these were distinct
entities. A few studies did not explicitly follow ICHD-II
or ICHD-I [78,89-93]. As to timeframe, most studies
reported 1-year prevalences. Some reported lifetime
prevalence [26,32,37,44,49,50,54,58,64,69,70,80,81,94-108]
and others reported shorter timeframes [28,31,80,81,90,
109-112] (e.g., 3 months). A considerable number reported
no timeframe [21,39,41,42,46,51,52,57,63,66,71,73,75-79,92,
93,108,113-123].
Most studies used a two-stage procedure for case as-
certainment: participants were first asked whether they
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those who did were posed the diagnostic questions.
Most studies then applied structured diagnostic question-
naires. Usually these were explicitly “based on ICHD-II”
(or ICHD-I), but many studies referred to “modifications”
of these criteria without indicating what these were. Not
all studies reported diagnostic validation. Some did but
attempted validation among headache patients in clinic
rather than in a sample drawn from the population of
interest [5,89,124-126].
We found few studies conducting burden estimations
that were both relevant and comprehensive [3-5,40]. Many
studies reported only prevalence; some reported symptom
burden (usually in terms of frequency, intensity and dur-
ation); some included limited enquiry into functional im-
pact (commonly using the migraine disability assessment
(MIDAS) questionnaire [127]). A very few reported bur-
den on others [41,128] and four estimated societal eco-
nomic impact [9,129-131]. Only three [4,5,40] explicitly
addressed the limitations of recall, a factor inherent in
enquiries into burden over past periods of time (often
three months).
All of these methodological shortcomings could be,
and often were, compounded by deficiencies in quality
of reporting.
Discussion
In the following, under the various themes, we discuss
the issues of concern and highlight how methodological
shortcomings might have detrimental impact on study
quality.
Study design
Most published studies used appropriate designs. This
might have been because most were of headache preva-
lence, requiring simpler cross-sectional designs. There
was a tendency in some to overstep the limitations of
these designs, which cannot for example produce evidence
of causation to identify risk factors. The few studies that
explicitly set out to define causal or risk factors for
headache recognized the need for case-control or cohort
designs.
The population of interest
In headache research, the population of interest is usu-
ally the population of a whole country, because national
data are needed for health policy, but there may be good
reasons to study regions larger [40] or smaller [5] than a
country. Depending on the aim of the study, sub-
populations defined by additional characteristics may be
perfectly legitimate subjects of study: specific age groups
(e.g., adults of working age, adolescents, school or pre-
school children); members of groups defined by ethni-
city, culture or language; workers in certain trades orprofessions, or university students; people with another
particular disease, etc. Headache patient populations on
the other hand, while they are easily accessed, are rarely
of interest: they are highly selected and, furthermore, the
criteria by which they are selected (often self-selected)
are generally indeterminable. A study of such populations
tells little about, and cannot be extrapolated to, either
the general population or any more broadly-defined
population.
Sampling, and bias avoidance
It is rarely possible to survey everyone in the population
of interest, and usually necessary to choose from that
population a smaller, manageable sample of people to
whom access is possible. Because the intention is to
generalize the data from this sample to the whole popu-
lation of interest, the essential requirement is that it
should remain representative of the population of interest.
“Representative” means similar to the population of inter-
est in all properties of relevance to (i.e., likely to influence)
the object of measurement (here, headache prevalence
and/or burden). In the context of headache, representa-
tiveness clearly encompasses age and gender, which are
known to affect headache prevalence, and probably should
encompass socioeconomic class, employment status, area
of habitation (rural or urban), ethnicity and possibly native
language and/or tribal group.
Random sampling from the entire population of interest,
either simple or stratified, depends upon chance to achieve
representativeness, with likelihood of success dependent
on sample size. In most cases, random sampling depends
on the existence of some form of overview of the popula-
tion: for example, census data, population registers or a
map showing all households in an area to be sampled.
Studies adopting this method usually sampled by tele-
phone: an established methodology, offering cheap and
easy access. In addition, this method is possible in the
absence of a population overview such as a complete
telephone directory through the technique of random
digit-dialling (dialling area code(s) followed randomly
by as many digits as are typical for phone numbers in
the area(s)) [132]. Telephone sampling can work well in
countries where telephones (land-line or mobile) are
both widespread and evenly distributed across different
age, gender and socioeconomic groups; otherwise, it is
open to serious selection bias.
Many studies employed some form of cluster sam-
pling, usually selecting participants from a limited num-
ber of defined geographical areas (e.g., blocks or streets,
or parts of villages), themselves chosen randomly. This
method is logistically efficient when selected partici-
pants are to be visited. In countries with obligatory
schooling, representative samples of children of school
age can be obtained by selecting all, or a random
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schools (a form of cluster sampling).
Generally, in headache studies, only one member of a
family is selected. Members of families are similar genet-
ically, share their environment and have common life-
styles; these factors effectively reduce variance if two or
more are included. Special issues therefore arise when
sampling is dependent upon contacts with households
rather than single persons (e.g., calling door-to-door or
by household telephone without prior warning). Within
a household, certain types of person are more likely to
stay at home, open the door or answer the phone: selec-
tion bias will inevitably arise when the person inter-
viewed is whoever happens to answer.Sample size determination
Sample-size requirement depends on the prevalence of
the disorder and the precision of the estimates needed.
Table 2 shows the margins of error for a prevalence of
10% (taken as an example) associated with sample sizes
ranging from 200 to 10,000. By increasing the sample
size from 200 to 2,000, the margin of error is decreased
from 4.2% to 1.3% (absolute), but the gain from sample
sizes of >2,000 is relatively small.
A larger sample may be needed to estimate burden
than to estimate prevalence, because burden is not
distributed equally among cases: most of it is accounted
for by a minority of those with the disorder. In a Swedish
survey, for example, 27% of people with migraine reported
68% of all attacks [133]. Among all people with migraine,
TTH or MOH, the relatively few with MOH have the
highest individual burden [9].Participation and non-participation
Sampling merely selects intended subjects, who become
participants only when accessed and engaged (which en-
tails procuring their willing cooperation so that the en-
quiry can be completed). A high level of non-participation
is potentially damaging to representativeness, although
how much so depends on the factors responsible for it
[134]. Non-participation results mostly from outright
refusal: a key factor in headache studies is that people
with headache, having a personal interest, are more
likely to participate, promoting a form of selection bias
that can be highly misleading. Also in headache studies,
non-participation is not a constant between important
subgroups (e.g., young males are often least willing).Table 2 Margin of error (95% confidence interval)
according to sample size
Sample size (N) 200 500 1,000 2,000 5,000 10,000
Margin of error (%) 4.2 2.7 1.9 1.3 0.8 0.6As an access method, visits to households permit
face-to-face interviews, which is the most direct method
of engagement, allowing physical examination where
this is a necessary part of the enquiry. Telephone inter-
views are almost as direct, without allowing physical
examination. Access by mail is cheap, and by e-mail even
cheaper, but both methods presume the use of self-
administered questionnaires (also cheap, but requiring a
high degree of literacy). The lack of engagement with an
interviewer provides no encouragement to respond and
no opportunity for clarifications; participation rates are
generally low, incomplete returns are common and selec-
tion bias is unavoidable because certain types of people
are inherently less likely to reply. Summoning prospective
participants to the interviewer is time-consuming for them
and invites bias with regard to who are willing and have
the time.
Caseness and ascertainment
In studies whose purpose is to assess headache prevalence,
or describe its characteristics, case definition – what pre-
cisely is meant by “headache” (or its types and subtypes,
when these are to be considered) – is of obvious and fun-
damental importance. The criteria of ICHD-II [82] are
currently the common language of definition, and descrip-
tion, of headache disorders.
Caseness must have a timeframe. This said, inconsistent
terminology in headache has arisen, largely because many
headache disorders are chronic but with episodic manifes-
tations. An “active headache disorder” is, by definition,
characterized by the occurrence of symptoms within the
previous year [82]. Prevalence studies that adopt this def-
inition of a case (i.e., an individual who reports at least one
headache episode during that time) necessarily use a time-
frame of 1 year and usually report the findings as “1-year
prevalence”. Strictly speaking, these are estimates of the
number of current cases (point prevalence). A different en-
quiry that defines a case only when symptoms are actually
present (“headache now” or “headache yesterday” [40])
also estimates point prevalence, but of headache attacks or
headache as a symptom rather than of a headache dis-
order. We found most studies reported 1-year prevalence.
Other timeframes, especially lifetime prevalence, are rele-
vant to particular purposes (e.g., genetic studies). Shorter
timeframes (e.g., 3 months) are difficult to relate, whilst
studies specifying no timeframe lack useful case definition.
The two-stage procedure for case ascertainment (only
participants responding affirmatively to a screening ques-
tion are posed the diagnostic questions) is time saving, but
with a potential penalty: a negative answer to the screen-
ing question terminates further enquiry, even though it
can be false.
For epidemiological purposes, diagnostic criteria are
almost always built into a structured questionnaire,
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clinic. ICHD-II criteria were not designed for epi-
demiological enquiry, and are not particularly well-
suited to it. For several reasons, modifications of
ICHD-II are almost invariably necessary. First, their
strict application would require that all participants be
personally interviewed and in many cases examined by
a competent clinician. In most cases, even if possible,
this would be a questionable use of resources. Second,
ICHD-II criteria are expressed in technical language,
and must be translated for lay participants without
loss or distortion of meaning. Third, certain criteria
distinguishing between migraine and TTH pose par-
ticular problems in epidemiological surveys, noted
empirically in studies within the Global Campaign
[3-5]. It has been found difficult to gather correct
responses on headache duration, requiring patients to
consider untreated attacks, which they may never have
or last had long ago. There are no easy lay explana-
tions of photo- and phonophobia, which are technical
concepts, and it is even more difficult to specify what
degrees of photo- and phonophobia fulfil migraine
criteria in ICHD-II.
The separate reporting of prevalences of migraine and
probable migraine (or TTH and probable TTH), as
though these were distinct entities, is highly problem-
atic. ICHD-II sets the general rule that, when all but
one criterion for disorder X are met, the diagnosis is
“probable X” (provided that not all criteria are met for
another disorder Y, in which case the correct diagnosis
is Y). This has an important purpose in clinical manage-
ment, providing a basis for a treatment plan pending
later diagnostic confirmation. In epidemiological sur-
veys, later confirmation is not expected: initial diagno-
ses of probable X have no opportunity to be amended
either to X or to another diagnosis. In the specific cases
of migraine and TTH, diagnosis of the former depends
upon the presence of specific features (e.g., nausea,
vomiting, photophobia and phonophobia, aggravation
by physical activity), while diagnosis of TTH depends
essentially upon the absence of these same features. By
ICHD-II rules, the presence of all but one feature of
migraine is not consistent with a diagnosis of TTH, and
must lead to a diagnosis of probable migraine. The same
is true of probable TTH. Yet there are unavoidable un-
certainties in questionnaire-based diagnoses, with the
consequence that, according to ICHD rules, about half
of such diagnoses are probable while, in validation stud-
ies conducted in sub-groups of the same populations,
fewer than 10% of expert diagnoses are probable (unre-
ported data from Ayzenberg et al. [3], Yu et al. [4] and
Rao et al. [5]). It is difficult to see that the concept of
“probable X” (as something distinct from “X”) serves
any purpose in studies of population health.Validation of the diagnostic questionnaire
Validation proves the diagnostic capability, in the popu-
lation of interest, of the diagnostic questionnaire. It
gains importance when modifications of ICHD-II cri-
teria are adopted, which is almost always necessary (see
above). It must, to achieve its purpose, be performed
either in a separate sample of the population of interest,
selected by identical methodology to the main sample,
or in a randomly or consecutively selected sub-sample
of participants in the main study. Headache patients in
clinic are especially unrepresentative of any population
of interest in terms of their headache disorders and,
probably, a range of other relevant factors. They com-
monly have more knowledge of headache, and perform
differently from non-clinic populations when answering
questionnaires because they have rehearsed their histories.
Validation is not always possible. In countries where
there are no headache experts, there is no gold standard
available. In such cases only, going ahead without diagnos-
tic validation may be justifiable, because the alternative is
that research of public-health importance can never be
commenced. What should then be avoided is the inven-
tion of a new and untested questionnaire, rather than
adopt one that has at least been used previously and vali-
dated in multiple languages and cultures.
Burden estimation
This area of enquiry is being developed by LTB in Global
Campaign studies in Russia [3], China [4], India [5],
Pakistan [6], Saudi Arabia, Zambia, Ethiopia, Nepal and
Guatemala (not yet published). “Relevant” implies that
measured burden must be attributable to headache, and
not to any other cause (including comorbidity). Burden
of headache has many different elements. “Comprehen-
siveness” requires that all are measured if a full account
is needed. However, the purpose of the study can legitim-
ately restrict the enquiry to specific elements (for example,
financial burden [9]).
Some elements of burden are not quantifiable, but
amenable only to qualitative (descriptive) analysis. In all
cases of burden estimation (more so than for prevalence
estimation because of the complexities of burden), the
limitations of recall are an important factor in the
generation of information bias.
Elements of burden
Symptom burden in common headache disorders arises
from pain, and, in migraine, additionally from nausea,
vomiting and photo- and/or phonophobia. While present,
these symptoms may cause debility and prostration, and
reduce functional ability. The consequences include inabil-
ity to work. This secondary disability burden is magnified
because headache is most common in people between
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Attached to disability may be a cost burden from lost pay.
To the extent that this arises from lost wages, as a conse-
quence of absenteeism, it is a relevant and important com-
ponent of the burden of headache for many people.
However, housewives and unemployed people may have
no income to lose. In other cases, this cost is only a small
part of the personal burden because it is largely borne by
employers or insurers, contributing instead to the very
high societal economic burden.
Headache attacks are unpleasant; people who experience
them frequently worry about when the next may occur.
They may identify triggers, and attempt to eliminate them
by lifestyle compromise. Leisure activities may be cancelled
or curtailed because of headache; when many social events
have been cancelled, they are likely not to be planned in
the first place. These are all elements of interictal burden,
which may be sufficient to impair quality of life. The great
importance of interictal burden lies in the fact that it is
continuous, rather than present only during attacks occur-
ring perhaps every 30 days. This means both that it should
not be ignored and that, if over-estimated, it will greatly
distort overall burden quantification.
A consequence of recurring inability to work may be de-
creased probability of promotion, with failure to develop full
career potential. A consequence of lost school-time may be
reduced career opportunities. In both cases, the result is
lower pay and impaired financial security. Over a lifetime,
the cumulative burden of financial losses can be substantial.
A summary measure of overall individual burden is
unlikely to be comprehensive, but the concept is attractive
for its simplicity. Measures of quality of life are very non-
specific, but comparison with a matched non-headache
group may provide a useful indicator of burden expressed
in very broad terms.
Burden on others, unaffected by headache themselves,
arises in several ways. Employers and work colleagues
carry part of it when paid-for work is not done: either
the employer pays for nothing, or colleagues take on
extra duties to make up. Family and friends lose the
companionship they reasonably expect, but which is not
given by a person shut away in a dark room. Children
may not always be looked after. Partners and other fam-
ily members may inherit increased shares of chores and
responsibilities. They may acquire a carer burden, called
to look after the person with headache. Carers, as well
as the sufferer, can lose time from work.
Health-care resource consumption, when direct treat-
ment costs for a condition affecting a large proportion of
the population are reimbursed by a state-funded health
system, is a substantial contributor to societal economic
burden. But by far the greater part of the financial cost of
headache is the indirect cost of absenteeism and reduced
effectiveness at work [9,130].Reporting of methods and results
Methods can be assessed only according to how they are
reported. While we found that methodological shortcom-
ings were often compounded by deficiencies in quality of
reporting, it might sometimes be the case (but this can
never be known) that methods were better than the
reporting of them indicated.
The same is true of results.
Conclusions
There is worldwide neglect of headache disorders as major
causes of public ill-health, and inadequate responses to
them in countries throughout the world [135]. In this con-
text, population-based studies of headache inform needs
assessment and are the essential guide for provision of
headache services and the commitment of appropriate
resources to them. Quality assurance in the design,
conduct and reporting of them is as important as in
clinical trials, but this fact has not been well recog-
nized. The literature reveals many issues, highlighted
here, that require attention.
A full account of burden, which should underpin needs
assessment, requires a rather detailed enquiry. The meth-
odology is still under development.
The production, publication and dissemination of expert
guidance, empirically tested, would be of major benefit – a
large step towards improving quality in population surveys
of headache prevalence, burden and cost. It is a necessary
step in the path towards addressing these inadequate
responses.
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